Pregnant Hemophilia B Carriers Have Three Times the Risk of Postpartum Hemorrhage, Swedish Study Finds
Pregnant women who are hemophilia B carriers have more than three times the risk of bleeding following childbirth than…
Articles by Ana Pena, PhD
Updated Alta Trial Results Support Advancement of SB-525 Gene Therapy for Hemophilia A
Updated results from the Alta trial show that a single infusion with the highest dose of SB-525, an…
Marstacimab Improves Clotting in Hemophilic Blood Samples Tested in Lab, Study Reports
Marstacimab, an experimental treatment in clinical testing for hemophilia A and B, was able to restore clotting…
Hemlibra Superior to Factor VIII Therapies in Hemophilia A Patients Without Inhibitors, Trial Data Show
Preventive treatment with Hemlibra (emicizumab)Â is superior to replacement therapy with factor VIII infusions for reducing bleed rates…
Preclinical Work by Sigilon Supports Cell Therapies as Durable Way of Treating Bleeding Disorders
Cell therapies may be a feasible way of achieving a long-term correction of bleeding disorders, preclinical data shared by…
Gene Therapy for Hemophilia A, SB-525, Showing Continued Benefits in Trial Data Update
The ongoing Phase 1/2 Alta trial continues to show that a single infusion of SB-525, an investigational gene…
Decision-making for Hemophilia Treatment Differs Between US and UK Doctors, Study Finds
U.S. doctors caring for people with hemophilia are more likely to make treatment…
Gene Therapy AMT-061 Effective 6 Months After Single Dose in Hemophilia B Patients, Ongoing Phase 2b Trial Suggests
A single infusion of AMT-061, an investigational gene therapy for hemophilia B, continues to…
Poor Joint Health, Chronic Pain in Children Increase Caregiver Burden, European Study Says
Bleeding episodes, chronic pain, and the presence of inhibitors in children with hemophilia cause emotional stress for caregivers and increase their…
Higher Doses of Adynovate is Effective as Preventive Treatment for Hemophilia A, Trial Suggests
Maintaining high concentrations of Adynovate in the blood of hemophilia A patients decreases…